At every step of the research process from the lab to the clinic, we are pursuing innovative ways to prevent and control cancer.
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence algorithms to use its output to design personalized cancer vaccines for patients.
The December 2024 issue of Ludwig Link includes a rich lineup of research briefs, Q&As and a deep dive into a research initiative at Ludwig Lausanne.
Three Ludwig Center trainees took a few minutes out of their very busy schedules to tell us about their lives, scientific fascinations, avocational passions and views on a variety of issues.
